Yuao Zhu

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · Nature Communications · 2021 · 284 citations · Full text

Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B Virus

William E. Delaney, Adrian S. Ray, Huiling Yang et al. · Antimicrobial Agents and Chemotherapy · 2006 · 255 citations · Full text

Immunology, Hepatitis B, Cell Culture +20

Genotype and Subtype Profiling of PSI-7977 as a Nucleotide Inhibitor of Hepatitis C Virus

Angela M. Lam, Christine Espiritu, Shalini Bansal et al. · Antimicrobial Agents and Chemotherapy · 2012 · 240 citations · Full text

Hepatitis C Virus, Genetics, Molecular Biology +19

Kinetics of Hepadnavirus Loss from the Liver during Inhibition of Viral DNA Synthesis

Yuao Zhu, Toshiki Yamamoto, John M. Cullen et al. · Journal of Virology · 2001 · 223 citations · Full text

No Resistance to Tenofovir Disoproxil Fumarate Detected After up to 144 Weeks of Therapy in Patients Monoinfected With Chronic Hepatitis B Virus Δ

Andrea Snow‐Lampart, Brandi Chappell, Maria Curtis et al. · Hepatology · 2010 · 177 citations · Full text